Browsing by Subject "Buprenorphine"
Now showing items 1-9 of 9
-
Association of chronic non-cancer pain status and buprenorphine treatment retention among individuals with opioid use disorder: Results from electronic health record data.
(Drug and alcohol dependence reports, 2022-06)<h4>Background</h4>Although chronic non-cancer pain (CNCP) is common among individuals with opioid use disorder (OUD), its impact on buprenorphine treatment retention is unclear. The goal of this study was to use electronic ... -
Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.
(Addiction (Abingdon, England), 2016-12)<h4>Aims</h4>To assess the safety of buprenorphine compared with methadone to treat pregnant women with opioid use disorder.<h4>Methods</h4>We searched PubMed, Embase and the Cochrane Library from inception to February 2015 ... -
Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence.
(The American journal of psychiatry, 2011-07) -
Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.
(Current drug abuse reviews, 2012-03)Constant refinement of opioid dependence (OD) therapies is a condition to promote treatment access and delivery. Among other applications, the partial opioid agonist buprenorphine has been studied to improve evidence-based ... -
Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial.
(Drug and alcohol dependence, 2014-05)The approval of extended release injectable naltrexone (XR-NTX; Vivitrol(®)) has introduced a new option for treating opioid addiction, but studies are needed to identify its place within the spectrum of available therapies. ... -
Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective?
(Addiction (Abingdon, England), 2019-08)<h4>Context and purpose</h4>Measurement-based care (MBC) is an evidence-based health-care practice in which indicators of disease are tracked to inform clinical actions, provide feedback to patients and improve outcomes. ... -
Opioid use disorder deaths and the effects of medication therapy.
(The American journal of drug and alcohol abuse, 2019-01) -
Pramipexole Augmentation of Buprenorphine Improves Pain and Depression in Opioid Use Disorder: A Case Report.
(The primary care companion for CNS disorders, 2020-10-15) -
Withdrawal severity and early response to treatment in the outpatient transition from opioid use to extended release naltrexone.
(The American journal on addictions, 2018-09)BACKGROUND AND OBJECTIVES:Long acting naltrexone has improved the therapy of opioid use disorder (OUD), and safe and effective withdrawal management during naltrexone induction may help advance treatment. Despite the uncertain ...
